EP-7041

N/A

Report date: 2025/05/30 11:13:40
NME

Base Information

Drug NameEP-7041
Drug Alias NameEP-7041HSK-36273
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor XIa inhibitors
TargetsCoagulation factor XI
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)ThrombocytopeniaBlood Coagulation Disorders +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesExithera Pharmaceuticals Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesCadrenal Therapeutics IncHaisco Pharmaceutical Group Co Ltd
Inactive CompaniesExithera Pharmaceuticals Inc
Active IndicationsBlood Coagulation DisordersThrombosisThromboembolism +[4] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Thrombocytopenia

Other Information

ATC CodeN/A
Related LinksN/A